Clinical Trial Update: A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 concordance study comparing insulin treatments in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED